E-ISSN 2148-5607
RELATED ARTICLES
Editorial
Effects of Giardia lamblia infestation on the clinical sourse of cronic hepatitis B
(Turk J Gastroenterol 1998; 9: 24-27)
Acral erythema induced bu interferon alpha in a child
(Turk J Gastroenterol 1998; 9: 70-72)
Osteoporosis and bone metabolism in cirrhotic patients
(Turk J Gastroenterol 1998; 9: 95-100)
The action of a calcium channel blocker (verapamil) on gallbloadder contractions
(Turk J Gastroenterol 1998; 9: 123-125)
The effects of ciprofloxacin and ursodeoxycholic acid on bacterial translocation in obstructive jaundice
(Turk J Gastroenterol 2009; 20: 168-191)
DOI: 10.4318/tjg.2009.0005
An asymptomatic huge hepatocellular carcinoma with intra-atrial tumor thrombus in a patient with chronic hepatitis B viral infection
(Turk J Gastroenterol 2006; 17: 203-205)
Assessment of bone metabolism and mineral density in chronic viral hepatitis
(Turk J Gastroenterol 2006; 17: 260-266)
Immunomodulatory effects of HBsAg vaccine and levamisole in chronic hepatitis B and hepatitis B carrier children
(Turk J Gastroenterol 2005; 16: 188-193)
Effects of calcium channel blocking agents on tetracycline hepatotxicity
(Turk J Gastroenterol 1996; 7: 6-9)
Bone mineral dansity in inflamatory bowel disease
(Turk J Gastroenterol 1997; 8: 295-299)
Effect of interferon treatment on glucose metabolism in children with chronic hepatitis B infection
(Turk J Gastroenterol 2004; 15: 4-10)
Autoantibodies in children with chronic hepatitis B infection and the influence of interferon alpha
(Turk J Gastroenterol 2004; 15: 213-218)
Predictive value of proliferating cell nuclear antigen index in response to interferon treatment in patients with chronic viral hepatitis B and C
(Turk J Gastroenterol 2001; 12: 89-94)
The effect of recombinant hepatitis B vaccine therapy in chronic hepatitis B infection
(Turk J Gastroenterol 2002; 13: 6-10)
Determination of serum hepatitis B virus DNA in chronic HBsAg carriers: Clinical significance and correlation with serological markers
(Turk J Gastroenterol 2003; 14: 157-163)
A comparative immunohistochemical study of HBsAg, HBcAg and CD57 in chronic hepatitis B pediatric patients with and without malignant disorders
(Turk J Gastroenterol 2003; 14: 234-238)
Evaluation of the outcome of interferon therapy in chronic hepatitis B infection
(Turk J Gastroenterol 1999; 10: -)
Prevalence of osteoporosis in liver cirrhosis
(Turk J Gastroenterol 1997; 8: 156-159)
Determination of intracellular Th1/Th2 type cytokines in lymphocytes of chronic hepatitis B patients treated with interferon-alpha
(Turk J Gastroenterol 2010; 21: 401-410)
DOI: 10.4318/tjg.2010.0127
Relationship between serum levels of interleukin-10, interleukin-2 and soluble intercellular adhesion molecule-I and liver injury in chronic hepatitis B virus infection
(Turk J Gastroenterol 1999; 10: 243-248)
Review
Emerging therapeutics and relevant targets for chronic Hepatitis B
(Turk J Gastroenterol 2016; 27: 210-215)
DOI: 10.5152/tjg.2016.15521
Which drugs are risk factors for the development of gastroesophageal reflux disease?
(Turk J Gastroenterol 2017; 28: 38-43)
DOI: 10.5152/tjg.2017.11
Case Report
A case of gynecomastia due to entecavir
(Turk J Gastroenterol 2010; 21: 313-316)
DOI: 10.4318/tjg.2010.0108
A case of entecavir resistance which is developed after complete viral suppression during entecavir treatment for nucleoside-naive chronic hepatitis B
(Turk J Gastroenterol 2014; 25: 206-209)
DOI: 10.5152/tjg.2014.3605
Original Article
AST-platelet ratio index in the prediction of significant fibrosis and cirrhosis in patients with chronic hepatitis B
(Turk J Gastroenterol 2012; 23: 353-358)
DOI: 10.4318/tjg.2012.0348
Comparison of the efficacy of tenofovir and entecavir for the treatment of nucleos(t)ide-naive patients with chronic hepatitis B
(Turk J Gastroenterol 2012; 23: 247-252)
DOI: 10.4318/tjg.2012.0380
Proton pump inhibitor use for 12 months is not associated with changes in serum magnesium levels: a prospective open label comparative study
(Turk J Gastroenterol 2017; 28: 104-109)
DOI: 10.5152/tjg.2016.0284
Poster
Bone health in liver transplant recipients: Corticosteroids preserve their significance, what about late follow-up?
(Turk J Gastroenterol 2019; 30: 21-22)
DOI: 10.5152/tjg.2019.11
Efficacy of entecavir treatment for up to 5 years in patients with HBV-related compensated cirrhosis in Turkey; real life data
(Turk J Gastroenterol 2019; 30: 36-36)
DOI: 10.5152/tjg.2019.22
Evaluation of 24-year followig results of patients with inactive hepatitis B
(Turk J Gastroenterol 2019; 30: 55-55)
DOI: 10.5152/tjg.2019.35
A case with chronic HBV infection who was non-responder to nucleos(t)ide analogues was treated with Pegylated interferon
(Turk J Gastroenterol 2019; 30: 70-72)
DOI: 10.5152/tjg.2019.47
Clinical and laboratory features of children with chronic hepatitis B infection: A single center results
(Turk J Gastroenterol 2019; 30: 74-74)
DOI: 10.5152/tjg.2019.49
Clinical outcomes after cessation of potent antiviral treatment in chronic hepatitis B patients
(Turk J Gastroenterol 2019; 30: 81-82)
DOI: 10.5152/tjg.2019.54
Effect of vitamin D levels and osteoporosis on survival in patients with chronic liver disease awaiting liver transplantation
(Turk J Gastroenterol 2019; 30: 83-84)
DOI: 10.5152/tjg.2019.55
Poster Presentation
The evaluation of liver biopsy specimens of chronic hepatitis B patients using early tissue markers for Hepatocellular Carcinoma: Before and after the development of Hepatocellular Carcinoma
(Turk J Gastroenterol 2019; 30: 102-102)
DOI: 10.5152/tjg.2019.67
Key Words
Authors
All
Reviewer's Corner
Author’s Corner
Survey
AVES | Copyright © 2019 Turkish Society of Gastroenterology | Latest Update: 04.07.2019